Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Cronos Australia Ltd. ( (AU:VIT) ) has shared an announcement.
Vitura Health Limited, through its joint venture Flora Holdings Pty Ltd, has acquired the Heyday Medical Clinic, a respected medicinal cannabis clinic in Australia. This acquisition strengthens Flora’s clinical network, positioning it as a leader in holistic healthcare, and expands patient access to both face-to-face and telehealth consultations. The deal involves acquiring key assets of Heyday Medical, with Vitura contributing 50% of the acquisition cost. The transition will see Heyday’s clinical team continue under Flora, enhancing the joint venture’s capacity to deliver quality patient care.
The most recent analyst rating on (AU:VIT) stock is a Buy with a A$0.12 price target. To see the full list of analyst forecasts on Cronos Australia Ltd. stock, see the AU:VIT Stock Forecast page.
More about Cronos Australia Ltd.
Vitura Health Limited is a leading digital health platform in Australia, focusing on traditional and emerging therapies. The company is involved in a joint venture, Flora Holdings Pty Ltd, which aims to enhance integrated holistic healthcare through acquisitions like the Heyday Medical Clinic.
Average Trading Volume: 415,742
Technical Sentiment Signal: Sell
Current Market Cap: A$46.36M
For an in-depth examination of VIT stock, go to TipRanks’ Stock Analysis page.